Country Profile

Denmark

Denmark is a growing market for Indian pharmaceuticals — $55.8M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 78% of shipments. The compound annual growth rate since FY2015 stands at 4.3%.

🇩🇰 $55.8M · 1.6× growth since FY2015 · 4.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$55.8M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.3%
CAGR FY2015→2026
78%
Medicines Share
4
Product Categories Supplied
Denmark is a growing market for Indian pharmaceuticals — $55.8M in FY 2025–26, with 1.6× growth over the past decade. Medicines accounts for 78% of shipments. The compound annual growth rate since FY2015 stands at 4.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $43.5M (78.1%) Medicine Ingredients $7.32M (13.1%) Surgical & Hospital Supplies $3.89M (7.0%) Traditional & Herbal $1.02M (1.8%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Denmark in the RBI overseas direct investment dataset (2011–2026).